Table 5.
Relative risk and correlation between intervention groups and principal clinical outcomes.
| MRD + 45 | Induction Response | Relapse | |||||||
|---|---|---|---|---|---|---|---|---|---|
| r | RR (IC95%) |
p-Value | r | RR (IC95%) |
p-Value | r | RR (IC95%) |
p-Value | |
|
CG
(n = 6) |
0.03 | 0.889 (0.245–3.226) |
0.619 | 0.25 | 0.480 (0.189–1.220) |
0.138 | 0.07 | 0.802 (2.95–2.180) |
0.479 |
|
REG
(n = 5) |
−0.09 | 1.333 (0.422–1.679) |
0.453 | 0.03 | 0.917 (0.349–2.406) |
0.576 | −0.06 | 1.200 (0.407–3.539) |
0.530 |
|
CEG
(n = 7) |
0.06 | 0.800 (0.224–2.855) |
0.547 | −0.10 | 1.375 (0.460–4.108) |
0.424 | −0.19 | 2.000 (0.529–7.557) |
0.236 |
MRD: minimal residual disease; RR: relative risk; CG: Control Group; REG: Resistance Exercise Group; CEG: Cross-training Exercise Group. Values are shown as RR (CI 95%). A p-value < 0.05 was considered a statistical significance parameter.